Table II.

Our cohort divided according to the Mladina classification. Disease-specific QOL scores (mean and standard deviation) assessed with the NOSE scale at baseline; 3 and 6 months after surgery.

Deviation	Sample rate (%)	Baseline	3 months	6 months
I	11.8%	14.1 ± 1.2	12.3 ± 1.7	12.0 ± 1.9
II	13.5%	16.0 ± 1.0	15.6 ± 1.0	15.5 ± 1.0
III	20.3%	15.0 ± 0.8	14.5 ± 0.9	14.1 ± 0.6
IV	6.7%	17.8 ± 0.5	11.0 ± 3.7	10.2 ± 3.3
V	23.7%	18.1 ± 1.3	0.8 ± 0.4	0.7 ± 0.4
VI	18.6%	17.6 ± 1.4	7.9 ± 7.7	7.7 ± 6.7
VII	5%	16.6 ± 1.2	15.3 ± 0.6	15 ± 1.0